🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8846770

Controlled release aural pressure modulator compositions and methods for the treatment of

The Regents of the University of California · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846643

Phosphonates with reduced toxicity for treatment of viral infections

The Regents of the University of California · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846629

Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and

The Regents of the University of California · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846627

Method for treatment of malaria

East China University of Science and Technology · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8840905

Use of neurotoxin therapy for treatment of urologic and related disorders

The Regents of the University of Colorado · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841273

Methods and compositions for anti-EGFR treatment

The Board of Regents of the University of Texas System · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8835491

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbala

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8834854

Oral treatment compositions and related methods of manufacture

Ranir, LLC · Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8829030

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828980

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828971

Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and ass

GALECTIN THERAPEUTICS, INC. · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828380

Method for the treatment of pulmonary disease and method of producing proteins of use ther

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828356

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822540

Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822196

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of s

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8821880

Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

China Synthetic Rubber Corporation · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8815951

Inhibitors of epoxide hydrolases for the treatment of inflammation

The Regents of the University of California · Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8815240

Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

China Synthetic Rubber Corporation · Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8809310

Use of rasagiline for the treatment of multiple system atrophy

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8809291

Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and othe

The Regents of the University of California · Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8802844

Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8802689

Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-ass

The Regents of the University of California · Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8796302

Methods related to the treatment of neurodegenerative and inflammatory conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8795964

GRM3 mutations and use thereof for the diagnosis and treatment of melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted